To evaluate the continued safety and performance of the Reva Fantom Sirolismus-Eluting Bioresorbable Coronary Scaffold in nativ coronary arteries that includes incorporation of a deformable expansion technologgy and an enhanced scaffold material (Tyr...

Clinical Studies - May 6, 2024 - Jun 30, 2030

Ongoing

Project leader: Rigger Johannes
Members: Fink Karin, Schneider Irene

A prospective, randomized, multicenter, international, open, clinical study in which the SELUTION DEB strategy was compared with the DES strategy. Study objectives: 1) At 1 year, to demonstrate non-inferiority for TVF of a treatment strategy wi...

Clinical Studies - Sep 28, 2023 - Sep 28, 2028

Ongoing

Project leader: Rigger Johannes
Members: Meier Jessica, Schneider Irene

This study is a single armed, prospective, multi-center, observational study Planned: up to 40 study sites in the EU and selected non-EU-countries

Clinical Studies - Oct 21, 2021 - Dec 31, 2026

Ongoing

Project leader: Rigger Johannes
Members: Vetsch Susanne, Fink Karin

Titel: instantaneous wave-free ratio guided Multivessel revascularizatiOn During percutaneous coronary intervEntion for acute myocaRdial iNfarction Objective: To compare an iFR-guided intervention of noninfarct lesions during the acute interventi...

Clinical Studies - Jan 20, 2019 - Dec 31, 2024

Ongoing

Project leader: Rigger Johannes
Members: Schneider Irene

Double-Blind, Randomized, Multi-Center, Placebo-Controlled, Parallel Group Study to Determine the Effects of Evolocumab (AMG 145) Treatment on Atherosclerotic Disease Burden As Measured By Intravascular Ultrasound in Subjects Undergoing Coronary Cath...

Clinical Studies - Jan 9, 2014 - Jan 9, 2018

Completed

Project leader: Rickli Hans
Members: Weilenmann Daniel, Gemperle Michaela, Rigger Johannes

A Multicenter Open-label Extension (OLE) Study to Assess the Long-term Safety and Efficacy of AMG 145 Study Phase: 3 Indication: Primary hyperlipidemia and mixed dyslipidemia Primary Objective: To characterize the safety and tolerability of long-ter...

Clinical Studies - Sep 20, 2013 - Sep 20, 2017

Completed

Project leader: Rickli Hans
Members: Gemperle Michaela, Rigger Johannes

Ziel der Studie ist es, die Praxis der OAK in der Schweiz zu erfassen und insbesondere die Häufigkeit der INR-Messungen und die Häufigkeit eines INR-Wertes im Ziel-Bereich von 2-3 bei Patienten mit VHF festzuhalten. Es wird insbesondere untersucht ob...

Clinical Studies - Jan 1, 2011 - Dec 31, 2014

Completed

Project leader: Rickli Hans, Maeder Micha
Members: Arquint Flurina, Rigger Johannes, Schneider Irene